| 摘要 |
The invention provides methods, uses and compositions for the treatment of Crohn's disease. The invention describes methods and uses for treating Crohn's disease, wherein a TNFalpha inhibitor, such as a human TNFalpha antibody, or antigen-binding portion thereof, is used to induce and maintain remission of Crohn's disease in a subject. Also described are methods for determining the efficacy of a TNFalpha inhibitor for treatment of Crohn's disease in a subject. |
